GSK, AstraZeneca Partner to Tackle Covid-19 Test Shortages
07 Abril 2020 - 8:30AM
Noticias Dow Jones
By Dieter Holger
AstraZeneca PLC and GlaxoSmithKline PLC have teamed up with the
University of Cambridge to combat shortages of Covid-19 tests, the
companies said Tuesday.
The British drug companies said they would set up a laboratory
at the university to develop "alternative chemical reagents for
test kits in order to help overcome current supply shortages."
"While diagnostic testing is not part of either company's core
business, we are moving as fast as we can to help where possible,"
the companies said.
In late March, GSK joined a coalition of drugmakers who agreed
to share their "proprietary libraries of molecular compounds" for
screening with the Covid-19 Therapeutics Accelerator, which was
launched by the Bill & Melinda Gates Foundation, Mastercard
Inc. and U.K.-based nonprofit Wellcome.
That effort could result in human or animal trials in as little
as two months, the Gates Foundation said at the time.
Write to Dieter Holger at dieter.holger@wsj.com;
@dieterholger
(END) Dow Jones Newswires
April 07, 2020 09:15 ET (13:15 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024